Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple Sclerosis.

Fernández O, Arroyo R, Martínez-Yélamos S, Marco M, Merino GJA, Muñoz D, Merino E, Roque A, RELOAD Study Group

PLoS One. 2016; 11(8):e0160313. Epub 2016 Aug 15. PMID: 27526201. Abstract